Author

Avery Bodlak

University of Colorado AnschutzORCID 0000-0001-9207-1532Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Organism:human· 2 Assay:scRNA-seq· 2 Approach:statistical model· 2 Research Focus:cell-cell communication· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Andrew E. GoodspeediD· 2 shared Masanori HayashiiD· 2 shared Aaron Michael TayloriD· 1 shared Adam D. LindsayiD· 1 shared Alexis B. DuffyiD· 1 shared Alini Trujillo-PaolilloiD· 1 shared Alissa M. DzisiD· 1 shared Amy Treece· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Andrew E. GoodspeedORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyCancersPeer-reviewedJun 24, 2025

Immunosuppressive tumor microenvironment of osteosarcoma

Aaron Michael Taylor, Jianting Sheng, Patrick Kwok Shing Ng…·Ching C. Lau

This study identifies immunosuppressive mechanisms in osteosarcoma using single-cell and spatial transcriptomics, revealing interactions between MDSCs, T-cells, and tumor cells that promote an immunosuppressive microenvironment.

39 citationstop 1%

humanscRNA-seq

𝕏 PostBluesky

Cancer BiologyClinical Cancer ResearchPeer-reviewedMar 3, 2025

Characterization of transcriptional heterogeneity and novel therapeutic targets using single cell RNA-sequencing of primary and circulating Ewing sarcoma cells.

Andrew E. Goodspeed, Avery Bodlak, Alexis B. Duffy…·Masanori Hayashi

This study uses single-cell RNA-sequencing to analyze transcriptional heterogeneity in Ewing sarcoma and identifies TSPAN8 as a novel therapeutic target.

21 citationstop 2%

humanscRNA-seq

𝕏 PostBluesky